JERUSALEM—Israel on Sunday began offering a COVID-19 booster to children as young as 12, and its prime minister said a campaign that began a month ago among seniors has slowed a rise in severe illness caused by the Delta variant. Announcing the decision, top Israeli health officials said the effectiveness of the second dose of…
Israel Lowers Age of Eligibility for COVID-19 Vaccine Booster to 30: Health Ministry
Israel expanded its COVID-19 vaccine booster shots to those over 30 years old on Tuesday, broadening its booster campaign amid a surge in the Delta variant. A statement from the Health Ministry said its decision to lower the age of eligibility for a third dose of the Pfizer/BioNtech vaccine from 40 to 30 followed a…
Biden Admin Recommends COVID-19 Booster Shots, Will Start Wide Distribution on Sept. 20
The United States will begin widely distributing COVID-19 booster shots next month and will recommend them for most Americans who received the vaccine, according to several top federal health officials. A joint statement from Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky, National Institutes of Health Director Francis Collins, National Institute of Allergy…
Pfizer-BioNTech and Moderna Poised to Make Billions on COVID-19 Boosters
Moderna and the Pfizer-BioNTech alliance could reap billions from COVID-19 booster shots in the coming years, in what analysts and investors say could be a market comparable to the $6 billion in annual sales for flu vaccines. Pfizer, its German partner BioNTech, and Moderna have together locked in over $60 billion in sales of their…
CDC Panel Recommends Third COVID-19 Vaccine Dose for Immunocompromised
A Centers for Disease Control and Prevention (CDC) advisory panel on Friday voted 11–0 for additional COVID-19 vaccine booster shots for individuals who are immunocompromised. The decision applies to only those who have received two doses of the mRNA vaccines made by Moderna or Pfizer, not the Johnson & Johnson vaccine. Immunocompromised people–including individuals who…
CDC Panel Recommends 3rd COVID-19 Vaccine Dose for Immunocompromised
A Centers for Disease Control and Prevention (CDC) advisory panel on Friday voted 11–0 for additional COVID-19 vaccine booster shots for individuals who are immunocompromised. The decision applies to only those who have received two doses of the mRNA vaccines made by Moderna or Pfizer, not the Johnson & Johnson vaccine. Immunocompromised people—including individuals who…
Israel Tightens Coronavirus Restrictions as New Cases Surge
JERUSALEM—Israel’s government on Wednesday advanced a raft of new coronavirus restrictions, including sweeping implementation of a digital vaccine passport and tighter restrictions on mass gatherings, as the country struggles with skyrocketing new infections. The country that had appeared to put the coronavirus pandemic behind it a few months ago after one of the biggest vaccine…
Germany, UK to Offer COVID-19 Booster Shots to Certain Groups From September
Germany and the UK have both announced plans to offer a COVID-19 booster shot as soon as next month. The booster shot in Germany will be prioritized for those deemed to be more at risk, such as people who don’t have strong immune systems or the immunocompromised, from next month, while in the UK, some…
AstraZeneca, Still Unsure of Need for COVID-19 Booster
This story originally appeared on ValueWalk Pascal Soriot, CEO of AstraZeneca plc, said the company still doesn’t know if a third dose of its COVID-19 vaccine will be necessary to maintain protection against the virus. Time Will Tell Soriot told CNBC: “There are two dimensions to this immunity—antibodies [which] decline over time, but the second,…
Delayed Second Shot and Third ‘Booster’ of AstraZeneca’s COVID Vaccine Offer Strong Immune Responses: Study
A new study into AstraZeneca’s COVID-19 vaccine shows that a second dose administered later than within the recommended 4–12 week period after the first one offered greater protection, while a third dose led to a further increase in immune response and protection against viral variants, offering both greater flexibility in vaccination schedules and showing promise…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`